Drug intelligence / Profile preview

MKS-5

Development stage
Unknown
Lead developer
Medika Natura
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

MKS-5 is a standardized botanical extract (phytopharmaceutical) developed by the Malaysian company Medika Natura. Derived from the medicinal plant *Orthosiphon stamineus* (commonly known as Misai Kucing), MKS-5 is being developed for several therapeutic indications. Its most advanced program is for the treatment of urinary tract infections (UTI), which has reached Phase 2 clinical trials. Additionally, the compound is undergoing Phase 1 evaluation for its potential as an analgesic and anti-inflammatory agent, as well as for cardiovascular applications, specifically in the management of hypertension. The extract is designed to provide a consistent, pharmaceutical-grade version of traditional herbal remedies, leveraging the plant's known diuretic and anti-inflammatory properties.

Other names
Orthosiphon stamineus extract

Beyond the preview

Go deeper on MKS-5.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MKS-5.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call